Browse by Journal Title

2023

Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura.
Völker, L.A. and Kaufeld, J. and Balduin, G. and Merkel, L. and Kühne, L. and Eichenauer, D.A. and Osterholt, T. and Hägele, H. and Kann, M. and Grundmann, F. and Kolbrink, B. and Schulte, K. and Gäckler, A. and Kribben, A. and Boss, K. and Potthoff, S.A. and Rump, L.C. and Schmidt, T. and Mühlfeld, A.S. and Schulmann, K. and Hermann, M. and Gaedeke, J. and Sauerland, K. and Bramstedt, J. and Hinkel, U.P. and Miesbach, W. and Bauer, F. and Westhoff, T.H. and Bruck, H. and Buxhofer-Ausch, V. and Müller, T.J. and Wendt, R. and Harth, A. and Schreiber, A. and Seelow, E. and Tölle, M. and Gohlisch, C. and Bieringer, M. and Geuther, G. and Jabs, W.J. and Fischereder, M. and von Bergwelt-Baildon, A. and Schönermarck, U. and Knoebl, P. and Menne, J. and Brinkkoetter, P.T.
Journal of Thrombosis and Haemostasis 21 (3): 559-572. March 2023

2018

High and long-term von Willebrand factor expression after Sleeping Beauty transposon-mediated gene therapy in a mouse model of severe von Willebrand disease.
Portier, I. and Vanhoorelbeke, K. and Verhenne, S. and Pareyn, I. and Vandeputte, N. and Deckmyn, H. and Goldenberg, D.S. and Samal, H.B. and Singh, M. and Ivics, Z. and Izsvák, Z. and De Meyer, S.F.
Journal of Thrombosis and Haemostasis 16 (3): 592-604. March 2018

2009

Serotonin stimulates platelet receptor shedding by tumor necrosis factor-alpha-converting enzyme (ADAM17).
Duerschmied, D. and Canault, M. and Lievens, D. and Brill, A. and Cifuni, S.M. and Bader, M. and Wagner, D.D.
Journal of Thrombosis and Haemostasis 7 (7): 1163-1171. July 2009